Literature DB >> 24590034

Pneumocystis pneumonia following rituximab.

Joshua D Farkas1, Ryan D Clouser2, Garth W Garrison2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24590034     DOI： 10.1378/chest.13-2539

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  2 in total

1.  Anti-CD20 antibody therapy and susceptibility to Pneumocystis pneumonia.

Authors:  Waleed Elsegeiny; Taylor Eddens; Kong Chen; Jay K Kolls
Journal:  Infect Immun       Date:  2015-03-02       Impact factor: 3.441

2.  Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice.

Authors:  Guixiang Dai; Kristin Noell; Gisbert Weckbecker; Jay K Kolls
Journal:  mSphere       Date:  2021-05-05       Impact factor: 4.389
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.